Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective study

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Eye

• Publication date

  2015-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/eye.2015.36PMID 25853447PMCID PMC4469668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.

  2014cited by this paper
• Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

  2014cited by this paper
• EFFICACY AND SAFETY OF TWO OR MORE DEXAMETHASONE INTRAVITREAL IMPLANT INJECTIONS FOR TREATMENT OF MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION (SHASTA STUDY)

  2014cited by this paper
• Retreatment with Ozurdex for Macular Edema Secondary to Retinal Vein Occlusion

  2014cited by this paper
• Author Reply To: Retreatment with Ozurdex for Macular Edema Secondary to Retinal Vein Occlusion

  2014cited by this paper
• Aqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case series

  2013cited by this paper
• Treatment of Macular Edema Associated with Retinal vein Occlusion Using Sustained-release Dexamethasone Implants in a Clinical Setting

  2013cited by this paper
• Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6‐month follow‐up – The SOLO study

  2013cited by this paper
• Proteomic analysis of aqueous humor from patients with branch retinal vein occlusion-induced macular edema.

  2013cited by this paper
• Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice

  2013cited by this paper
• Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion

  2013cited by this paper
• Efficacy and Safety of Intravitreal Therapy in Macular Edema Due to Branch and Central Retinal Vein Occlusion: a Systematic Review

  2013cited by this paper
• Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.

  2012cited by this paper
• Steroids and Macular Edema from Retinal Vein Occlusion

  2011cited by this paper
• Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

  2011cited by this paper
• Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

  2011cited by this paper
• Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

  2010cited by this paper
• Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

  2010cited by this paper

• Real-life experience of Dexamethasone implant under a proactive treatment regimen: The ProDEX Study.

  2024cites this paper
• Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery

  2023cites this paper
• Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea

  2021cites this paper
• Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study

  2019cites this paper
• Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience

  2018cites this paper
• The Pattern of Recurrence in Diabetic Macular Edema Treated by Dexamethasone Implant: The PREDIAMEX Study.

  2017cites this paper
• Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment

  2016cites this paper
• Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial

  2016cites this paper